E-Mail
ROCHESTER, Minn. You might be older - or younger - than you think. A new study found that differences between a person s age in years and his or her biological age, as predicted by an artificial intelligence (AI)-enabled EKG, can provide measurable insights into health and longevity.
The AI model accurately predicted the age of most subjects, with a mean age gap of 0.88 years between EKG age and actual age. However, a number of subjects had a gap that was much larger, either seemingly much older or much younger by EKG age.
The likelihood to die during follow-up was much higher among those seemingly older by EKG age, compared to those whose EKG age was the same as their chronologic or actual age. The association was even stronger when predicting death caused by heart disease. Conversely, those who had a lesser age gap ? considered younger by EKG - had decreased risk.
You might be older ― or younger ― than you think. A new study found that differences between a person's age in years and his or her biological age, as.
E-Mail
Sophia Antipolis, 19 May 2021: Cities harbour a dangerous cocktail of environmental stressors which politicians must tackle to save lives and preserve health. That s the conclusion of a paper published today in
European Heart Journal, a journal of the European Society of Cardiology (ESC).1 By 2050, three in four people will live in cities, where up to 80% of energy is consumed and 70% of greenhouse gases are emitted, said study author Professor Thomas Münzel of the University Medical Centre Mainz, Germany. There are limited actions that individuals can take to protect themselves from pollutants so politicians and policy makers need to take on this responsibility.
Sophia Antipolis [France], May 19 (ANI): Cities harbour a dangerous cocktail of environmental stressors which politicians must tackle to save lives and preserve health- says the conclusion of a new paper.
(UPDATED) Looking once again at a question that many cardiologists considered settled, a new meta-analysis suggests that patients with stable coronary artery disease undergoing elective revascularization are at a lower risk of dying from cardiac causes over the long term when compared with patients treated with medical therapy alone.
The findings, presented today as a late-breaking clinical trial at EuroPCR 2021, and simultaneously published in the
European Heart Journal, seem to fly in the face of the randomized ISCHEMIA trial findings, published last year. In this analysis, the benefit appeared directly related to the duration of follow-up, with investigators reporting that the longer the follow-up, the lower the risk of cardiac death and spontaneous MI among those who underwent PCI or CABG surgery.